GelTech Solutions, Inc. (OTCBB: GLTC) this morning reported receipt of the first order from Turkey through partner Nano Girisim Ltd. Sti. Nano Girism Ltd. Sti., a distributor of industrial products based in Istanbul. Nano Girisim intends to initially promote GelTech’s FireIce, a revolutionary water enhancing fire suppressant for use in fire extinguishers, as Turkish law currently requires a fire extinguisher in every vehicle and apartment.
FireIce is a patent pending fire suppressant used for direct attack of fires as well as a medium term retardant for structure protection. FireIce can be used in all types of apparatus; fire extinguishers, pumper trucks, aerial units for wildfires and home defense units for personal home protection.
GelTech will also be looking to broaden its footprint domestically and abroad with its Soil₂O product, a non-toxic soil conditioner and a dust abatement product. Sales kicked-off in April with an initial order from West Chester Machinery, one of the largest privately-owned truck rental fleets engaged in controlling dust in construction and other commercial sites in North America.
“We are pleased to receive and process the first order from our Turkish distributor and look forward to their aggressive plan to bring FireIce and Soil₂O to market in Turkey,” said GelTech CEO Michael Cordani in a corporate statement. “We continue to believe that the current Turkish fire remediation legislation only re-affirms the need for our product.”
Shares of GLTC closed Monday at 94 cents.
GelTech Solutions (GLTC) Stock Quote and News:
Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.
Add your comment
Commenting is allowed only for registered users.